Logo image of EQVA.OL

EQVA ASA (EQVA.OL) Stock Fundamental Analysis

Europe - Euronext Oslo - OSL:EQVA - NO0010708605 - Common Stock

3.36 NOK
+0.04 (+1.2%)
Last: 12/15/2025, 7:00:00 PM
Fundamental Rating

3

EQVA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 113 industry peers in the Machinery industry. There are concerns on the financial health of EQVA while its profitability can be described as average. EQVA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

EQVA had positive earnings in the past year.
The reported net income has been mixed in the past 5 years: EQVA reported negative net income in multiple years.
In multiple years EQVA reported negative operating cash flow during the last 5 years.
EQVA.OL Yearly Net Income VS EBIT VS OCF VS FCFEQVA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.33%, EQVA is in the better half of the industry, outperforming 70.80% of the companies in the same industry.
With an excellent Return On Equity value of 15.88%, EQVA belongs to the best of the industry, outperforming 81.42% of the companies in the same industry.
EQVA's Return On Invested Capital of 6.44% is fine compared to the rest of the industry. EQVA outperforms 61.06% of its industry peers.
Industry RankSector Rank
ROA 5.33%
ROE 15.88%
ROIC 6.44%
ROA(3y)-0.99%
ROA(5y)14.41%
ROE(3y)-1.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EQVA.OL Yearly ROA, ROE, ROICEQVA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

EQVA has a Profit Margin (3.50%) which is in line with its industry peers.
In the last couple of years the Profit Margin of EQVA has declined.
EQVA has a Operating Margin of 2.99%. This is in the lower half of the industry: EQVA underperforms 73.45% of its industry peers.
EQVA's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 52.96%, EQVA is in the better half of the industry, outperforming 69.91% of the companies in the same industry.
EQVA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.99%
PM (TTM) 3.5%
GM 52.96%
OM growth 3Y-6.53%
OM growth 5YN/A
PM growth 3Y-58.16%
PM growth 5YN/A
GM growth 3Y19.37%
GM growth 5Y25.52%
EQVA.OL Yearly Profit, Operating, Gross MarginsEQVA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EQVA is destroying value.
The number of shares outstanding for EQVA has been increased compared to 1 year ago.
The number of shares outstanding for EQVA has been increased compared to 5 years ago.
The debt/assets ratio for EQVA has been reduced compared to a year ago.
EQVA.OL Yearly Shares OutstandingEQVA.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
EQVA.OL Yearly Total Debt VS Total AssetsEQVA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

EQVA has an Altman-Z score of 2.14. This is not the best score and indicates that EQVA is in the grey zone with still only limited risk for bankruptcy at the moment.
EQVA has a Altman-Z score (2.14) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.67 indicates that EQVA is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.67, EQVA is doing worse than 66.37% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Altman-Z 2.14
ROIC/WACC0.67
WACC9.62%
EQVA.OL Yearly LT Debt VS Equity VS FCFEQVA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 1.17 indicates that EQVA should not have too much problems paying its short term obligations.
The Current ratio of EQVA (1.17) is worse than 73.45% of its industry peers.
EQVA has a Quick Ratio of 1.14. This is a normal value and indicates that EQVA is financially healthy and should not expect problems in meeting its short term obligations.
EQVA has a better Quick ratio (1.14) than 61.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.14
EQVA.OL Yearly Current Assets VS Current LiabilitesEQVA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.36% over the past year.
The earnings per share for EQVA have been decreasing by -69.46% on average. This is quite bad
EQVA shows a strong growth in Revenue. In the last year, the Revenue has grown by 53.41%.
The Revenue for EQVA have been decreasing by -13.86% on average. This is quite bad
EPS 1Y (TTM)26.36%
EPS 3Y-69.46%
EPS 5YN/A
EPS Q2Q%-32.26%
Revenue 1Y (TTM)53.41%
Revenue growth 3Y5.52%
Revenue growth 5Y-13.86%
Sales Q2Q%26.78%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EQVA.OL Yearly Revenue VS EstimatesEQVA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 5.01, which indicates a rather cheap valuation of EQVA.
EQVA's Price/Earnings ratio is rather cheap when compared to the industry. EQVA is cheaper than 99.11% of the companies in the same industry.
EQVA is valuated cheaply when we compare the Price/Earnings ratio to 26.55, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 5.01
Fwd PE N/A
EQVA.OL Price Earnings VS Forward Price EarningsEQVA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EQVA is valued a bit cheaper than the industry average as 68.14% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.33
EQVA.OL Per share dataEQVA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for EQVA!.
Industry RankSector Rank
Dividend Yield 0%

EQVA ASA

OSL:EQVA (12/15/2025, 7:00:00 PM)

3.36

+0.04 (+1.2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.7%
Inst Owner ChangeN/A
Ins Owners1.62%
Ins Owner ChangeN/A
Market Cap279.48M
Revenue(TTM)1.71B
Net Income(TTM)59.98M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.2
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.01
Fwd PE N/A
P/S 0.16
P/FCF N/A
P/OCF N/A
P/B 0.74
P/tB 32.2
EV/EBITDA 7.33
EPS(TTM)0.67
EY19.94%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS20.6
BVpS4.54
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Graham Number8.27
Profitability
Industry RankSector Rank
ROA 5.33%
ROE 15.88%
ROCE 7.5%
ROIC 6.44%
ROICexc 7.89%
ROICexgc 23.47%
OM 2.99%
PM (TTM) 3.5%
GM 52.96%
FCFM N/A
ROA(3y)-0.99%
ROA(5y)14.41%
ROE(3y)-1.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y43.23%
ROICexgc growth 5YN/A
ROICexc growth 3Y-31.72%
ROICexc growth 5YN/A
OM growth 3Y-6.53%
OM growth 5YN/A
PM growth 3Y-58.16%
PM growth 5YN/A
GM growth 3Y19.37%
GM growth 5Y25.52%
F-ScoreN/A
Asset Turnover1.52
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Debt/EBITDA 3.8
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 1.14
Altman-Z 2.14
F-ScoreN/A
WACC9.62%
ROIC/WACC0.67
Cap/Depr(3y)46.03%
Cap/Depr(5y)117.5%
Cap/Sales(3y)0.84%
Cap/Sales(5y)1.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.36%
EPS 3Y-69.46%
EPS 5YN/A
EPS Q2Q%-32.26%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)53.41%
Revenue growth 3Y5.52%
Revenue growth 5Y-13.86%
Sales Q2Q%26.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-47.28%
EBIT growth 3Y-1.37%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y287.99%
FCF growth 3Y-30.53%
FCF growth 5YN/A
OCF growth 1Y328.57%
OCF growth 3Y-30.04%
OCF growth 5YN/A

EQVA ASA / EQVA.OL FAQ

What is the ChartMill fundamental rating of EQVA ASA (EQVA.OL) stock?

ChartMill assigns a fundamental rating of 3 / 10 to EQVA.OL.


What is the valuation status for EQVA stock?

ChartMill assigns a valuation rating of 3 / 10 to EQVA ASA (EQVA.OL). This can be considered as Overvalued.


How profitable is EQVA ASA (EQVA.OL) stock?

EQVA ASA (EQVA.OL) has a profitability rating of 4 / 10.


What is the financial health of EQVA ASA (EQVA.OL) stock?

The financial health rating of EQVA ASA (EQVA.OL) is 3 / 10.